{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:16:04Z","timestamp":1784740564086,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["Qian Ke He Ji Chu MS [2025] 414"],"award-info":[{"award-number":["Qian Ke He Ji Chu MS [2025] 414"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08173-3","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:54:50Z","timestamp":1777532090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SNHG12 drives gastric cancer progression by activating the Wnt\/\u03b2-catenin\u2013mediated serine synthesis pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Nianjie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taolang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1170-7522","authenticated-orcid":false,"given":"Kunming","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"5","key":"8173_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20(5):338\u201349. https:\/\/doi.org\/10.1038\/s41571-023-00747-0.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"8173_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"8173_CR3","doi-asserted-by":"publisher","first-page":"216338","DOI":"10.1016\/j.canlet.2023.216338","volume":"571","author":"E Andreucci","year":"2023","unstructured":"Andreucci E, Biagioni A, Peri S, Versienti G, Cianchi F, Staderini F, et al. The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs. Cancer Lett. 2023;571:216338. https:\/\/doi.org\/10.1016\/j.canlet.2023.216338.","journal-title":"Cancer Lett"},{"issue":"8","key":"8173_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/cac2.12459","volume":"43","author":"X Hu","year":"2023","unstructured":"Hu X, Ma Z, Xu B, Li S, Yao Z, Liang B, et al. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer. Cancer Commun (Lond). 2023;43(8):909\u201337. https:\/\/doi.org\/10.1002\/cac2.12459.","journal-title":"Cancer Commun (Lond)"},{"issue":"9","key":"8173_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.17219\/acem\/171258","volume":"32","author":"P Liu","year":"2023","unstructured":"Liu P, Wang J, Du W, Chen L. LncRNA SNHG12 promotes proliferation and migration of hepatic progenitor cells via the Wnt\/\u03b2-catenin pathway. Adv Clin Exp Med. 2023;32(9):1017\u201327. https:\/\/doi.org\/10.17219\/acem\/171258.","journal-title":"Adv Clin Exp Med"},{"issue":"5","key":"8173_CR6","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3390\/ijms25052621","volume":"25","author":"C Del D\u00edaz","year":"2024","unstructured":"Del D\u00edaz C, Fern\u00e1ndez Ace\u00f1ero MJ, Ortega Medina L. Molecular classifications in gastric cancer: a call for interdisciplinary collaboration. Int J Mol Sci. 2024;25(5):2621. https:\/\/doi.org\/10.3390\/ijms25052621.","journal-title":"Int J Mol Sci"},{"key":"8173_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s11658-024-00583-1","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang H, Li J, Ni X, Yan W, Chen Y, et al. Exosome-derived proteins in gastric cancer progression, drug resistance, and immune response. Cell Mol Biol Lett. 2024;29:157. https:\/\/doi.org\/10.1186\/s11658-024-00583-1.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"8173_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cmet.2022.12.017","volume":"35","author":"CH Tsai","year":"2023","unstructured":"Tsai CH, Chuang YM, Li X, Yu YR, Tzeng SF, Teoh ST, et al. Immunoediting instructs tumor metabolic reprogramming to support immune evasion. Cell Metab. 2023;35(1):118\u2013e337. https:\/\/doi.org\/10.1016\/j.cmet.2022.12.017.","journal-title":"Cell Metab"},{"key":"8173_CR9","doi-asserted-by":"publisher","first-page":"155615","DOI":"10.1016\/j.metabol.2023.155615","volume":"145","author":"P Zheng","year":"2023","unstructured":"Zheng P, Lin Z, Ding Y, Duan S. Targeting the dynamics of cancer metabolism in the era of precision oncology. Metabolism. 2023;145:155615. https:\/\/doi.org\/10.1016\/j.metabol.2023.155615.","journal-title":"Metabolism"},{"key":"8173_CR10","doi-asserted-by":"publisher","first-page":"104352","DOI":"10.1016\/j.phrs.2019.104352","volume":"149","author":"JD Zeng","year":"2019","unstructured":"Zeng JD, Wu WKK, Wang HY, Li XX. Serine and one-carbon metabolism: a bridge that links mTOR signaling and DNA methylation in cancer. Pharmacol Res. 2019;149:104352. https:\/\/doi.org\/10.1016\/j.phrs.2019.104352.","journal-title":"Pharmacol Res"},{"issue":"7831","key":"8173_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","volume":"586","author":"T Muthusamy","year":"2020","unstructured":"Muthusamy T, Cordes T, Handzlik MK, You L, Lim EW, Gengatharan J, et al. Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature. 2020;586(7831):790\u20135. https:\/\/doi.org\/10.1038\/s41586-020-2609-x.","journal-title":"Nature"},{"issue":"1","key":"8173_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25(1):27\u201342. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.009.","journal-title":"Cell Metab"},{"key":"8173_CR13","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.2147\/OTT.S238307","volume":"13","author":"X Zhao","year":"2020","unstructured":"Zhao X, Fu J, Tang W, Yu L, Xu W. Inhibition of serine metabolism promotes resistance to cisplatin in gastric cancer. Onco Targets Ther. 2020;13:4833\u201342. https:\/\/doi.org\/10.2147\/OTT.S238307.","journal-title":"Onco Targets Ther"},{"key":"8173_CR14","doi-asserted-by":"publisher","first-page":"e16594","DOI":"10.7717\/peerj.16594","volume":"12","author":"Y Shan","year":"2024","unstructured":"Shan Y, Liu D, Li Y, Wu C, Ye Y. The expression and clinical significance of serine hydroxymethyltransferase 2 in gastric cancer. PeerJ. 2024;12:e16594. https:\/\/doi.org\/10.7717\/peerj.16594.","journal-title":"PeerJ"},{"issue":"4","key":"8173_CR15","doi-asserted-by":"publisher","first-page":"119697","DOI":"10.1016\/j.bbamcr.2024.119697","volume":"1871","author":"L Li","year":"2024","unstructured":"Li L, Qin Y, Chen Y. The enzymes of serine synthesis pathway in cancer metastasis. Biochim Biophys Acta Mol Cell Res. 2024;1871(4):119697. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119697.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"16","key":"8173_CR16","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1038\/s41388-021-01749-x","volume":"40","author":"G Zhang","year":"2021","unstructured":"Zhang G, Yang Y, Hu H, Liu K, Li B, Zhu Y, et al. Energy stress-induced LINC01564 activates the serine synthesis pathway and facilitates hepatocellular carcinogenesis. Oncogene. 2021;40(16):2936\u201351. https:\/\/doi.org\/10.1038\/s41388-021-01749-x.","journal-title":"Oncogene"},{"key":"8173_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13046-023-02827-6","volume":"42","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wang H, Liu Q, Dai S, Tian G, Wei X, et al. LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement. J Exp Clin Cancer Res. 2023;42:246. https:\/\/doi.org\/10.1186\/s13046-023-02827-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"8173_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17(1):46. https:\/\/doi.org\/10.1186\/s13045-024-01563-4.","journal-title":"J Hematol Oncol"},{"key":"8173_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-021-02244-4","volume":"41","author":"S Dong","year":"2022","unstructured":"Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, et al. ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J Exp Clin Cancer Res. 2022;41:15. https:\/\/doi.org\/10.1186\/s13046-021-02244-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"8173_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/CBM-171046","volume":"22","author":"S Ding","year":"2018","unstructured":"Ding S, Qu W, Jiao Y, Zhang J, Zhang C, Dang S. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating Wnt\/\u03b2-catenin signaling pathway. Cancer Biomark. 2018;22(2):217\u201326. https:\/\/doi.org\/10.3233\/CBM-171046.","journal-title":"Cancer Biomark"},{"issue":"6","key":"8173_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold ME, Brimacombe KR, Chan SH, Rohde JM, Lewis CA, Swier LJ, et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol. 2016;12(6):452\u20138. https:\/\/doi.org\/10.1038\/nchembio.2070.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"8173_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41374-021-00697-6","volume":"102","author":"L Jin","year":"2022","unstructured":"Jin L, Kiang KM, Cheng SY, Leung GK. Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing MGMT expression and ROS-mediated DNA damage in glioblastoma. Lab Invest. 2022;102(2):194\u2013203. https:\/\/doi.org\/10.1038\/s41374-021-00697-6.","journal-title":"Lab Invest"},{"key":"8173_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2017.10.017","volume":"414","author":"SR Martins-Neves","year":"2018","unstructured":"Martins-Neves SR, Paiva-Oliveira DI, Fontes-Ribeiro C, Bov\u00e9e JV, Cleton-Jansen AM, Gomes CM. IWR-1, a tankyrase inhibitor, attenuates Wnt\/\u03b2-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft. Cancer Lett. 2018;414:1\u201315. https:\/\/doi.org\/10.1016\/j.canlet.2017.10.017.","journal-title":"Cancer Lett"},{"issue":"33","key":"8173_CR24","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41388-018-0285-1","volume":"37","author":"H Guo","year":"2018","unstructured":"Guo H, Zhao L, Shi B, Bao J, Zheng D, Zhou B, et al. GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90. Oncogene. 2018;37(33):4505\u201317. https:\/\/doi.org\/10.1038\/s41388-018-0285-1.","journal-title":"Oncogene"},{"issue":"1","key":"8173_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144. https:\/\/doi.org\/10.1186\/s12943-022-01616-7.","journal-title":"Mol Cancer"},{"issue":"1","key":"8173_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-023-04993-5","volume":"81","author":"W Xue","year":"2024","unstructured":"Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R. Wnt\/\u03b2-catenin-driven EMT regulation in human cancers. Cell Mol Life Sci. 2024;81(1):79. https:\/\/doi.org\/10.1007\/s00018-023-04993-5.","journal-title":"Cell Mol Life Sci"},{"key":"8173_CR27","doi-asserted-by":"publisher","first-page":"110736","DOI":"10.1016\/j.cellsig.2023.110736","volume":"109","author":"X Duan","year":"2023","unstructured":"Duan X, Chen Y, Zhang K, Chen W, Zhao J, Dai X, et al. PHGDH promotes esophageal squamous cell carcinoma progression via Wnt\/\u03b2-catenin pathway. Cell Signal. 2023;109:110736. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110736.","journal-title":"Cell Signal"},{"issue":"8","key":"8173_CR28","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-23-2080","volume":"84","author":"L Yan","year":"2024","unstructured":"Yan L, Wu M, Wang T, Yuan H, Zhang X, Zhang H, et al. Breast cancer stem cells secrete MIF to mediate tumor metabolic reprogramming that drives immune evasion. Cancer Res. 2024;84(8):1270\u201385. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2080.","journal-title":"Cancer Res"},{"issue":"8","key":"8173_CR29","doi-asserted-by":"publisher","first-page":"13066","DOI":"10.1002\/jcb.28589","volume":"120","author":"J Song","year":"2019","unstructured":"Song J, Wu X, Ma R, Miao L, Xiong L, Zhao W. Long noncoding RNA SNHG12 promotes cell proliferation and activates Wnt\/\u03b2-catenin signaling in prostate cancer through sponging microRNA-195. J Cell Biochem. 2019;120(8):13066\u201375. https:\/\/doi.org\/10.1002\/jcb.28589.","journal-title":"J Cell Biochem"},{"issue":"12","key":"8173_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00891-y","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13(12):877\u2013919. https:\/\/doi.org\/10.1007\/s13238-021-00891-y.","journal-title":"Protein Cell"},{"issue":"12","key":"8173_CR31","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/ijc.34588","volume":"152","author":"W Sun","year":"2023","unstructured":"Sun W, Zhao E, Cui H. Target enzymes in serine-glycine-one-carbon metabolic pathway for cancer therapy. Int J Cancer. 2023;152(12):2446\u201363. https:\/\/doi.org\/10.1002\/ijc.34588.","journal-title":"Int J Cancer"},{"key":"8173_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-023-06516-1","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Wang H, Li Y, Zhou Y, Zhang Q, et al. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 2024;15:42. https:\/\/doi.org\/10.1038\/s41419-023-06516-1.","journal-title":"Cell Death Dis"},{"key":"8173_CR33","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3389\/fonc.2019.00901","volume":"9","author":"S Tamang","year":"2019","unstructured":"Tamang S, Acharya V, Roy D, Sharma R, Aryaa A, Sharma U, et al. SNHG12: An lncRNA as a potential therapeutic target and biomarker for human cancer. Front Oncol. 2019;9:901. https:\/\/doi.org\/10.3389\/fonc.2019.00901.","journal-title":"Front Oncol"},{"issue":"6","key":"8173_CR34","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1755-148X.2011.00924.x","volume":"24","author":"E Mullarky","year":"2011","unstructured":"Mullarky E, Mattaini KR, Vander Heiden MG, Cantley LC, Locasale JW. PHGDH amplification and altered glucose metabolism in human melanoma. Pigment Cell Melanoma Res. 2011;24(6):1112\u20135. https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00924.x.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"8173_CR35","doi-asserted-by":"publisher","first-page":"BSR20171092","DOI":"10.1042\/BSR20171092","volume":"37","author":"Q Wu","year":"2017","unstructured":"Wu Q, Li J, Sun S, Chen X, Zhang H, Li B, et al. YAP\/TAZ-mediated activation of serine metabolism and methylation regulation is critical for LKB1-deficient breast cancer progression. Biosci Rep. 2017;37(5):BSR20171092. https:\/\/doi.org\/10.1042\/BSR20171092.","journal-title":"Biosci Rep"},{"issue":"10","key":"8173_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.31083\/j.fbl28010243","volume":"28","author":"H Li","year":"2023","unstructured":"Li H, Wu C, Chang W, Zhong L, Gao W, Zeng M, et al. Overexpression of PSAT1 is correlated with poor prognosis and immune infiltration in non-small cell lung cancer. Front Biosci (Landmark Ed). 2023;28(10):243. https:\/\/doi.org\/10.31083\/j.fbl28010243.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"8173_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9(2):176\u201398. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1177.","journal-title":"Cancer Discov"},{"key":"8173_CR38","doi-asserted-by":"publisher","first-page":"1508730","DOI":"10.3389\/fimmu.2025.1508730","volume":"16","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Tao Q, Qiao X, Yang Y, Peng C, Han M, et al. Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review. Front Immunol. 2025;16:1508730. https:\/\/doi.org\/10.3389\/fimmu.2025.1508730.","journal-title":"Front Immunol"},{"issue":"7650","key":"8173_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks ODK, Athineos D, Cheung EC, Lee P, Zhang T, van den Broek NJF, et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature. 2017;544(7650):372\u20136. https:\/\/doi.org\/10.1038\/nature22056.","journal-title":"Nature"},{"issue":"3","key":"8173_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7150\/ijbs.22626","volume":"14","author":"G Li","year":"2018","unstructured":"Li G, Su Q, Liu H, Wang D, Zhang W, Lu Z, et al. Frizzled7 promotes epithelial-to-mesenchymal transition and stemness via activating canonical Wnt\/\u03b2-catenin pathway in gastric cancer. Int J Biol Sci. 2018;14(3):280\u201393. https:\/\/doi.org\/10.7150\/ijbs.22626.","journal-title":"Int J Biol Sci"},{"key":"8173_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-022-01588-8","volume":"21","author":"L Zhou","year":"2022","unstructured":"Zhou L, Jiang J, Huang Z, Jin P, Peng L, Luo M, et al. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt\/\u03b2-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA. Mol Cancer. 2022;21:168. https:\/\/doi.org\/10.1186\/s12943-022-01588-8.","journal-title":"Mol Cancer"},{"key":"8173_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2021.09.019","volume":"525","author":"S Shang","year":"2022","unstructured":"Shang S, Wang J, Chen Z, Li W, Wang X, et al. The Wnt signaling pathway in cancer immunotherapy. Cancer Lett. 2022;525:84\u201396. https:\/\/doi.org\/10.1016\/j.canlet.2021.09.019.","journal-title":"Cancer Lett"},{"issue":"3","key":"8173_CR43","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.ymthe.2020.10.023","volume":"29","author":"Q Wu","year":"2021","unstructured":"Wu Q, Ma J, Wei J, Meng W, Wang Y, Shi M. LncRNA SNHG11 promotes gastric cancer progression by activating the Wnt\/\u03b2-catenin pathway and oncogenic autophagy. Mol Ther. 2021;29(3):1258\u201378. https:\/\/doi.org\/10.1016\/j.ymthe.2020.10.023.","journal-title":"Mol Ther"},{"issue":"4","key":"8173_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/ol.2020.12184","volume":"20","author":"P He","year":"2020","unstructured":"He P, Xiong G, Guo W, Jiang G, Li Y, Li H. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett. 2020;20(4):97. https:\/\/doi.org\/10.3892\/ol.2020.12184.","journal-title":"Oncol Lett"},{"issue":"9","key":"8173_CR45","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1182\/bloodadvances.2019001316","volume":"4","author":"JH Lee","year":"2020","unstructured":"Lee JH, Faderl S, Pagel JM, Jung CW, Yoon SS, Pardanani AD, et al. Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome. Blood Adv. 2020;4(9):2032\u201343. https:\/\/doi.org\/10.1182\/bloodadvances.2019001316.","journal-title":"Blood Adv"},{"issue":"1","key":"8173_CR46","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s13046-019-1342-5","volume":"38","author":"S Pak","year":"2019","unstructured":"Pak S, Park S, Kim Y, Park JH, Park CH, Lee KJ, et al. The small molecule WNT\/\u03b2-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res. 2019;38(1):342. https:\/\/doi.org\/10.1186\/s13046-019-1342-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"8173_CR47","doi-asserted-by":"publisher","first-page":"100985","DOI":"10.1016\/j.drup.2023.100985","volume":"70","author":"J Wang","year":"2023","unstructured":"Wang J, Zeng L, Wu N, Liang Y, Jin J, Fan M, et al. Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. Drug Resist Updat. 2023;70:100985. https:\/\/doi.org\/10.1016\/j.drup.2023.100985.","journal-title":"Drug Resist Updat"},{"key":"8173_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40164-021-00207-y","volume":"10","author":"S Elsaadi","year":"2021","unstructured":"Elsaadi S, Steiro I, Abdollahi P, Vandsemb EN, Yang R, Sl\u00f8rdahl TS, et al. Targeting phosphoglycerate dehydrogenase in multiple myeloma. Exp Hematol Oncol. 2021;10:3. https:\/\/doi.org\/10.1186\/s40164-021-00207-y.","journal-title":"Exp Hematol Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08173-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:56:41Z","timestamp":1778072201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08173-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8173"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08173-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent to participate in this study, which was approved by the Medical Ethics Review Committee of the Second Affiliated Hospital of Zunyi Medical University (approval no. KYLL-2025-084). The study strictly adhered to the principles of the Declaration of Helsinki (World Medical Association). Animal experiments were conducted in accordance with institutional guidelines for animal care and were approved by the Institutional Animal Care and Ethics Committee of the Affiliated Hospital of Zunyi Medical University (approval no. zyfy-2025-0304). Animal welfare was strictly ensured following the Guide for the Care and Use of Laboratory Animals, 8th edition (Washington, DC: National Academies Press, 2011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"638"}}